Af­ter a year of big in­vest­ments, Re­ci­pharm sells off as­sets in Eu­rope

Re­ci­pharm is hav­ing a yard sale to start the new year.

The com­pa­ny an­nounced a pair of deals Mon­day, as the Swedish biotech sold its Fontaine-lès-Di­jon, France man­u­fac­tur­ing site to a new­ly-es­tab­lished CD­MO As­trea Phar­ma. It al­so sold Aesi­ca Phar­ma­ceu­ti­cals and the ac­tive phar­ma­ceu­ti­cal in­gre­di­ent man­u­fac­tur­ing site in the UK to Phar­maron.

The sale will help stream­line Re­ci­pharm op­er­a­tions, and help its fi­nan­cial po­si­tion as it tries to break in­to a po­si­tion as a top-five CD­MO, CEO Marc Funk said in state­ments.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER